nodes	percent_of_prediction	percent_of_DWPC	metapath
Solifenacin—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.0767	0.206	CbGbCtD
Solifenacin—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.0566	0.152	CbGbCtD
Solifenacin—CYP3A4—Triamcinolone—rheumatoid arthritis	0.0429	0.115	CbGbCtD
Solifenacin—CYP3A4—Betamethasone—rheumatoid arthritis	0.0368	0.0989	CbGbCtD
Solifenacin—CYP3A4—Prednisolone—rheumatoid arthritis	0.0363	0.0976	CbGbCtD
Solifenacin—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.0344	0.0925	CbGbCtD
Solifenacin—CYP3A4—Prednisone—rheumatoid arthritis	0.0343	0.0922	CbGbCtD
Solifenacin—CYP3A4—Cyclosporine—rheumatoid arthritis	0.0325	0.0874	CbGbCtD
Solifenacin—CYP3A4—Dexamethasone—rheumatoid arthritis	0.0214	0.0575	CbGbCtD
Solifenacin—Benazepril—MTHFR—rheumatoid arthritis	0.00578	1	CrCbGaD
Solifenacin—Abdominal pain—Leflunomide—rheumatoid arthritis	0.000917	0.00191	CcSEcCtD
Solifenacin—Malnutrition—Methylprednisolone—rheumatoid arthritis	0.000916	0.00191	CcSEcCtD
Solifenacin—Dry mouth—Cyclosporine—rheumatoid arthritis	0.000914	0.00191	CcSEcCtD
Solifenacin—Angioedema—Prednisolone—rheumatoid arthritis	0.000912	0.0019	CcSEcCtD
Solifenacin—Hypersensitivity—Azathioprine—rheumatoid arthritis	0.000905	0.00189	CcSEcCtD
Solifenacin—Confusional state—Cyclosporine—rheumatoid arthritis	0.000903	0.00188	CcSEcCtD
Solifenacin—Dysgeusia—Triamcinolone—rheumatoid arthritis	0.000899	0.00188	CcSEcCtD
Solifenacin—Anaphylactic shock—Cyclosporine—rheumatoid arthritis	0.000895	0.00187	CcSEcCtD
Solifenacin—Eye disorder—Dexamethasone—rheumatoid arthritis	0.000894	0.00187	CcSEcCtD
Solifenacin—Eye disorder—Betamethasone—rheumatoid arthritis	0.000894	0.00187	CcSEcCtD
Solifenacin—Angioedema—Hydrocortisone—rheumatoid arthritis	0.000891	0.00186	CcSEcCtD
Solifenacin—Infection—Cyclosporine—rheumatoid arthritis	0.00089	0.00186	CcSEcCtD
Solifenacin—Nervous system disorder—Cyclosporine—rheumatoid arthritis	0.000878	0.00183	CcSEcCtD
Solifenacin—Skin disorder—Cyclosporine—rheumatoid arthritis	0.00087	0.00182	CcSEcCtD
Solifenacin—Angiopathy—Dexamethasone—rheumatoid arthritis	0.000868	0.00181	CcSEcCtD
Solifenacin—Angiopathy—Betamethasone—rheumatoid arthritis	0.000868	0.00181	CcSEcCtD
Solifenacin—Hypertension—Prednisolone—rheumatoid arthritis	0.000862	0.0018	CcSEcCtD
Solifenacin—Hypersensitivity—Leflunomide—rheumatoid arthritis	0.000855	0.00178	CcSEcCtD
Solifenacin—Hypertension—Hydrocortisone—rheumatoid arthritis	0.000842	0.00176	CcSEcCtD
Solifenacin—Angioedema—Triamcinolone—rheumatoid arthritis	0.000839	0.00175	CcSEcCtD
Solifenacin—Angioedema—Methylprednisolone—rheumatoid arthritis	0.000837	0.00175	CcSEcCtD
Solifenacin—Asthenia—Leflunomide—rheumatoid arthritis	0.000832	0.00174	CcSEcCtD
Solifenacin—Hallucination—Prednisone—rheumatoid arthritis	0.000829	0.00173	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—rheumatoid arthritis	0.000824	0.00172	CcSEcCtD
Solifenacin—Pruritus—Leflunomide—rheumatoid arthritis	0.000821	0.00171	CcSEcCtD
Solifenacin—Connective tissue disorder—Prednisone—rheumatoid arthritis	0.000819	0.00171	CcSEcCtD
Solifenacin—Anaphylactic shock—Prednisolone—rheumatoid arthritis	0.000815	0.0017	CcSEcCtD
Solifenacin—Dysuria—Methotrexate—rheumatoid arthritis	0.000814	0.0017	CcSEcCtD
Solifenacin—Dizziness—Azathioprine—rheumatoid arthritis	0.000812	0.0017	CcSEcCtD
Solifenacin—Cough—Triamcinolone—rheumatoid arthritis	0.000801	0.00167	CcSEcCtD
Solifenacin—Somnolence—Cyclosporine—rheumatoid arthritis	0.000796	0.00166	CcSEcCtD
Solifenacin—Anaphylactic shock—Hydrocortisone—rheumatoid arthritis	0.000796	0.00166	CcSEcCtD
Solifenacin—Tachycardia—Prednisolone—rheumatoid arthritis	0.000795	0.00166	CcSEcCtD
Solifenacin—Hypertension—Triamcinolone—rheumatoid arthritis	0.000793	0.00165	CcSEcCtD
Solifenacin—Hypertension—Methylprednisolone—rheumatoid arthritis	0.000791	0.00165	CcSEcCtD
Solifenacin—Infection—Hydrocortisone—rheumatoid arthritis	0.000791	0.00165	CcSEcCtD
Solifenacin—Dyspepsia—Cyclosporine—rheumatoid arthritis	0.000788	0.00164	CcSEcCtD
Solifenacin—Vomiting—Azathioprine—rheumatoid arthritis	0.000781	0.00163	CcSEcCtD
Solifenacin—Nervous system disorder—Hydrocortisone—rheumatoid arthritis	0.00078	0.00163	CcSEcCtD
Solifenacin—Eye disorder—Prednisone—rheumatoid arthritis	0.000779	0.00163	CcSEcCtD
Solifenacin—Decreased appetite—Cyclosporine—rheumatoid arthritis	0.000778	0.00162	CcSEcCtD
Solifenacin—Tachycardia—Hydrocortisone—rheumatoid arthritis	0.000777	0.00162	CcSEcCtD
Solifenacin—Infestation NOS—Methotrexate—rheumatoid arthritis	0.000776	0.00162	CcSEcCtD
Solifenacin—Infestation—Methotrexate—rheumatoid arthritis	0.000776	0.00162	CcSEcCtD
Solifenacin—Rash—Azathioprine—rheumatoid arthritis	0.000775	0.00162	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—rheumatoid arthritis	0.000775	0.00162	CcSEcCtD
Solifenacin—Dermatitis—Azathioprine—rheumatoid arthritis	0.000774	0.00162	CcSEcCtD
Solifenacin—Depression—Methotrexate—rheumatoid arthritis	0.000774	0.00161	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Cyclosporine—rheumatoid arthritis	0.000773	0.00161	CcSEcCtD
Solifenacin—Skin disorder—Hydrocortisone—rheumatoid arthritis	0.000773	0.00161	CcSEcCtD
Solifenacin—Fatigue—Cyclosporine—rheumatoid arthritis	0.000772	0.00161	CcSEcCtD
Solifenacin—Headache—Azathioprine—rheumatoid arthritis	0.00077	0.00161	CcSEcCtD
Solifenacin—Dizziness—Leflunomide—rheumatoid arthritis	0.000767	0.0016	CcSEcCtD
Solifenacin—Constipation—Cyclosporine—rheumatoid arthritis	0.000766	0.0016	CcSEcCtD
Solifenacin—Dry mouth—Triamcinolone—rheumatoid arthritis	0.000764	0.0016	CcSEcCtD
Solifenacin—Renal failure—Methotrexate—rheumatoid arthritis	0.000763	0.00159	CcSEcCtD
Solifenacin—Angioedema—Dexamethasone—rheumatoid arthritis	0.000761	0.00159	CcSEcCtD
Solifenacin—Angioedema—Betamethasone—rheumatoid arthritis	0.000761	0.00159	CcSEcCtD
Solifenacin—Angiopathy—Prednisone—rheumatoid arthritis	0.000756	0.00158	CcSEcCtD
Solifenacin—Confusional state—Methylprednisolone—rheumatoid arthritis	0.000754	0.00157	CcSEcCtD
Solifenacin—Immune system disorder—Prednisone—rheumatoid arthritis	0.000753	0.00157	CcSEcCtD
Solifenacin—Anaphylactic shock—Triamcinolone—rheumatoid arthritis	0.000749	0.00156	CcSEcCtD
Solifenacin—Anaphylactic shock—Methylprednisolone—rheumatoid arthritis	0.000748	0.00156	CcSEcCtD
Solifenacin—Infection—Triamcinolone—rheumatoid arthritis	0.000744	0.00155	CcSEcCtD
Solifenacin—Infection—Methylprednisolone—rheumatoid arthritis	0.000743	0.00155	CcSEcCtD
Solifenacin—Feeling abnormal—Cyclosporine—rheumatoid arthritis	0.000738	0.00154	CcSEcCtD
Solifenacin—Vomiting—Leflunomide—rheumatoid arthritis	0.000738	0.00154	CcSEcCtD
Solifenacin—Hepatobiliary disease—Methotrexate—rheumatoid arthritis	0.000734	0.00153	CcSEcCtD
Solifenacin—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	0.000733	0.00153	CcSEcCtD
Solifenacin—Gastrointestinal pain—Cyclosporine—rheumatoid arthritis	0.000732	0.00153	CcSEcCtD
Solifenacin—Rash—Leflunomide—rheumatoid arthritis	0.000732	0.00153	CcSEcCtD
Solifenacin—Tachycardia—Triamcinolone—rheumatoid arthritis	0.000731	0.00153	CcSEcCtD
Solifenacin—Dermatitis—Leflunomide—rheumatoid arthritis	0.000731	0.00153	CcSEcCtD
Solifenacin—Mental disorder—Prednisone—rheumatoid arthritis	0.00073	0.00152	CcSEcCtD
Solifenacin—Nausea—Azathioprine—rheumatoid arthritis	0.00073	0.00152	CcSEcCtD
Solifenacin—Tachycardia—Methylprednisolone—rheumatoid arthritis	0.00073	0.00152	CcSEcCtD
Solifenacin—Headache—Leflunomide—rheumatoid arthritis	0.000727	0.00152	CcSEcCtD
Solifenacin—Skin disorder—Methylprednisolone—rheumatoid arthritis	0.000726	0.00152	CcSEcCtD
Solifenacin—Malnutrition—Prednisone—rheumatoid arthritis	0.000725	0.00151	CcSEcCtD
Solifenacin—Hypertension—Dexamethasone—rheumatoid arthritis	0.000719	0.0015	CcSEcCtD
Solifenacin—Hypertension—Betamethasone—rheumatoid arthritis	0.000719	0.0015	CcSEcCtD
Solifenacin—Urticaria—Cyclosporine—rheumatoid arthritis	0.000711	0.00148	CcSEcCtD
Solifenacin—Abdominal pain—Cyclosporine—rheumatoid arthritis	0.000708	0.00148	CcSEcCtD
Solifenacin—Dyspepsia—Hydrocortisone—rheumatoid arthritis	0.0007	0.00146	CcSEcCtD
Solifenacin—Decreased appetite—Hydrocortisone—rheumatoid arthritis	0.000692	0.00144	CcSEcCtD
Solifenacin—Pharyngitis—Methotrexate—rheumatoid arthritis	0.000691	0.00144	CcSEcCtD
Solifenacin—Nausea—Leflunomide—rheumatoid arthritis	0.000689	0.00144	CcSEcCtD
Solifenacin—Urinary tract disorder—Methotrexate—rheumatoid arthritis	0.000688	0.00144	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.000687	0.00143	CcSEcCtD
Solifenacin—Fatigue—Hydrocortisone—rheumatoid arthritis	0.000686	0.00143	CcSEcCtD
Solifenacin—Vision blurred—Prednisone—rheumatoid arthritis	0.000684	0.00143	CcSEcCtD
Solifenacin—Urethral disorder—Methotrexate—rheumatoid arthritis	0.000683	0.00142	CcSEcCtD
Solifenacin—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	0.00068	0.00142	CcSEcCtD
Solifenacin—Anaphylactic shock—Betamethasone—rheumatoid arthritis	0.00068	0.00142	CcSEcCtD
Solifenacin—Infection—Betamethasone—rheumatoid arthritis	0.000675	0.00141	CcSEcCtD
Solifenacin—Infection—Dexamethasone—rheumatoid arthritis	0.000675	0.00141	CcSEcCtD
Solifenacin—Feeling abnormal—Prednisolone—rheumatoid arthritis	0.000671	0.0014	CcSEcCtD
Solifenacin—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.000667	0.00139	CcSEcCtD
Solifenacin—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.000667	0.00139	CcSEcCtD
Solifenacin—Tachycardia—Dexamethasone—rheumatoid arthritis	0.000664	0.00138	CcSEcCtD
Solifenacin—Tachycardia—Betamethasone—rheumatoid arthritis	0.000664	0.00138	CcSEcCtD
Solifenacin—Angioedema—Prednisone—rheumatoid arthritis	0.000663	0.00138	CcSEcCtD
Solifenacin—Hypersensitivity—Cyclosporine—rheumatoid arthritis	0.00066	0.00138	CcSEcCtD
Solifenacin—Dyspepsia—Triamcinolone—rheumatoid arthritis	0.00066	0.00138	CcSEcCtD
Solifenacin—Erythema multiforme—Methotrexate—rheumatoid arthritis	0.000659	0.00137	CcSEcCtD
Solifenacin—Dyspepsia—Methylprednisolone—rheumatoid arthritis	0.000658	0.00137	CcSEcCtD
Solifenacin—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	0.000656	0.00137	CcSEcCtD
Solifenacin—Eye disorder—Methotrexate—rheumatoid arthritis	0.000651	0.00136	CcSEcCtD
Solifenacin—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	0.000651	0.00136	CcSEcCtD
Solifenacin—Urticaria—Prednisolone—rheumatoid arthritis	0.000647	0.00135	CcSEcCtD
Solifenacin—Cardiac disorder—Methotrexate—rheumatoid arthritis	0.000646	0.00135	CcSEcCtD
Solifenacin—Fatigue—Triamcinolone—rheumatoid arthritis	0.000646	0.00135	CcSEcCtD
Solifenacin—Fatigue—Methylprednisolone—rheumatoid arthritis	0.000645	0.00135	CcSEcCtD
Solifenacin—Asthenia—Cyclosporine—rheumatoid arthritis	0.000642	0.00134	CcSEcCtD
Solifenacin—Pruritus—Cyclosporine—rheumatoid arthritis	0.000634	0.00132	CcSEcCtD
Solifenacin—Urticaria—Hydrocortisone—rheumatoid arthritis	0.000632	0.00132	CcSEcCtD
Solifenacin—Angiopathy—Methotrexate—rheumatoid arthritis	0.000632	0.00132	CcSEcCtD
Solifenacin—Immune system disorder—Methotrexate—rheumatoid arthritis	0.000629	0.00131	CcSEcCtD
Solifenacin—Abdominal pain—Hydrocortisone—rheumatoid arthritis	0.000629	0.00131	CcSEcCtD
Solifenacin—Mediastinal disorder—Methotrexate—rheumatoid arthritis	0.000628	0.00131	CcSEcCtD
Solifenacin—Hypertension—Prednisone—rheumatoid arthritis	0.000626	0.00131	CcSEcCtD
Solifenacin—Feeling abnormal—Triamcinolone—rheumatoid arthritis	0.000617	0.00129	CcSEcCtD
Solifenacin—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	0.000616	0.00129	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	0.000613	0.00128	CcSEcCtD
Solifenacin—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	0.000611	0.00128	CcSEcCtD
Solifenacin—Mental disorder—Methotrexate—rheumatoid arthritis	0.00061	0.00127	CcSEcCtD
Solifenacin—Malnutrition—Methotrexate—rheumatoid arthritis	0.000606	0.00127	CcSEcCtD
Solifenacin—Hypersensitivity—Prednisolone—rheumatoid arthritis	0.0006	0.00125	CcSEcCtD
Solifenacin—Dyspepsia—Betamethasone—rheumatoid arthritis	0.000598	0.00125	CcSEcCtD
Solifenacin—Dyspepsia—Dexamethasone—rheumatoid arthritis	0.000598	0.00125	CcSEcCtD
Solifenacin—Urticaria—Triamcinolone—rheumatoid arthritis	0.000595	0.00124	CcSEcCtD
Solifenacin—Urticaria—Methylprednisolone—rheumatoid arthritis	0.000594	0.00124	CcSEcCtD
Solifenacin—Dysgeusia—Methotrexate—rheumatoid arthritis	0.000594	0.00124	CcSEcCtD
Solifenacin—Dizziness—Cyclosporine—rheumatoid arthritis	0.000592	0.00124	CcSEcCtD
Solifenacin—Anaphylactic shock—Prednisone—rheumatoid arthritis	0.000592	0.00124	CcSEcCtD
Solifenacin—Abdominal pain—Methylprednisolone—rheumatoid arthritis	0.000591	0.00123	CcSEcCtD
Solifenacin—Decreased appetite—Dexamethasone—rheumatoid arthritis	0.000591	0.00123	CcSEcCtD
Solifenacin—Decreased appetite—Betamethasone—rheumatoid arthritis	0.000591	0.00123	CcSEcCtD
Solifenacin—Infection—Prednisone—rheumatoid arthritis	0.000588	0.00123	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.000587	0.00122	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.000587	0.00122	CcSEcCtD
Solifenacin—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	0.000586	0.00122	CcSEcCtD
Solifenacin—Fatigue—Betamethasone—rheumatoid arthritis	0.000586	0.00122	CcSEcCtD
Solifenacin—Fatigue—Dexamethasone—rheumatoid arthritis	0.000586	0.00122	CcSEcCtD
Solifenacin—Nervous system disorder—Prednisone—rheumatoid arthritis	0.000581	0.00121	CcSEcCtD
Solifenacin—Tachycardia—Prednisone—rheumatoid arthritis	0.000578	0.00121	CcSEcCtD
Solifenacin—Skin disorder—Prednisone—rheumatoid arthritis	0.000575	0.0012	CcSEcCtD
Solifenacin—Vision blurred—Methotrexate—rheumatoid arthritis	0.000571	0.00119	CcSEcCtD
Solifenacin—Asthenia—Hydrocortisone—rheumatoid arthritis	0.000571	0.00119	CcSEcCtD
Solifenacin—Vomiting—Cyclosporine—rheumatoid arthritis	0.000569	0.00119	CcSEcCtD
Solifenacin—Rash—Cyclosporine—rheumatoid arthritis	0.000565	0.00118	CcSEcCtD
Solifenacin—Dermatitis—Cyclosporine—rheumatoid arthritis	0.000564	0.00118	CcSEcCtD
Solifenacin—Pruritus—Hydrocortisone—rheumatoid arthritis	0.000563	0.00117	CcSEcCtD
Solifenacin—Headache—Cyclosporine—rheumatoid arthritis	0.000561	0.00117	CcSEcCtD
Solifenacin—Feeling abnormal—Dexamethasone—rheumatoid arthritis	0.00056	0.00117	CcSEcCtD
Solifenacin—Feeling abnormal—Betamethasone—rheumatoid arthritis	0.00056	0.00117	CcSEcCtD
Solifenacin—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	0.000556	0.00116	CcSEcCtD
Solifenacin—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	0.000556	0.00116	CcSEcCtD
Solifenacin—Hypersensitivity—Triamcinolone—rheumatoid arthritis	0.000552	0.00115	CcSEcCtD
Solifenacin—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	0.000551	0.00115	CcSEcCtD
Solifenacin—Urticaria—Dexamethasone—rheumatoid arthritis	0.00054	0.00113	CcSEcCtD
Solifenacin—Urticaria—Betamethasone—rheumatoid arthritis	0.00054	0.00113	CcSEcCtD
Solifenacin—Dizziness—Prednisolone—rheumatoid arthritis	0.000539	0.00112	CcSEcCtD
Solifenacin—Asthenia—Triamcinolone—rheumatoid arthritis	0.000538	0.00112	CcSEcCtD
Solifenacin—Abdominal pain—Dexamethasone—rheumatoid arthritis	0.000537	0.00112	CcSEcCtD
Solifenacin—Abdominal pain—Betamethasone—rheumatoid arthritis	0.000537	0.00112	CcSEcCtD
Solifenacin—Asthenia—Methylprednisolone—rheumatoid arthritis	0.000536	0.00112	CcSEcCtD
Solifenacin—Nausea—Cyclosporine—rheumatoid arthritis	0.000532	0.00111	CcSEcCtD
Solifenacin—Pruritus—Triamcinolone—rheumatoid arthritis	0.00053	0.00111	CcSEcCtD
Solifenacin—Cough—Methotrexate—rheumatoid arthritis	0.000529	0.0011	CcSEcCtD
Solifenacin—Pruritus—Methylprednisolone—rheumatoid arthritis	0.000529	0.0011	CcSEcCtD
Solifenacin—Dizziness—Hydrocortisone—rheumatoid arthritis	0.000526	0.0011	CcSEcCtD
Solifenacin—Dyspepsia—Prednisone—rheumatoid arthritis	0.000521	0.00109	CcSEcCtD
Solifenacin—Decreased appetite—Prednisone—rheumatoid arthritis	0.000515	0.00107	CcSEcCtD
Solifenacin—Rash—Prednisolone—rheumatoid arthritis	0.000514	0.00107	CcSEcCtD
Solifenacin—Dermatitis—Prednisolone—rheumatoid arthritis	0.000513	0.00107	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	0.000513	0.00107	CcSEcCtD
Solifenacin—Fatigue—Prednisone—rheumatoid arthritis	0.00051	0.00107	CcSEcCtD
Solifenacin—Headache—Prednisolone—rheumatoid arthritis	0.00051	0.00107	CcSEcCtD
Solifenacin—Constipation—Prednisone—rheumatoid arthritis	0.000506	0.00106	CcSEcCtD
Solifenacin—Vomiting—Hydrocortisone—rheumatoid arthritis	0.000506	0.00106	CcSEcCtD
Solifenacin—Rash—Hydrocortisone—rheumatoid arthritis	0.000502	0.00105	CcSEcCtD
Solifenacin—Dermatitis—Hydrocortisone—rheumatoid arthritis	0.000501	0.00105	CcSEcCtD
Solifenacin—Confusional state—Methotrexate—rheumatoid arthritis	0.000499	0.00104	CcSEcCtD
Solifenacin—Headache—Hydrocortisone—rheumatoid arthritis	0.000499	0.00104	CcSEcCtD
Solifenacin—Dizziness—Triamcinolone—rheumatoid arthritis	0.000495	0.00103	CcSEcCtD
Solifenacin—Anaphylactic shock—Methotrexate—rheumatoid arthritis	0.000495	0.00103	CcSEcCtD
Solifenacin—Dizziness—Methylprednisolone—rheumatoid arthritis	0.000494	0.00103	CcSEcCtD
Solifenacin—Infection—Methotrexate—rheumatoid arthritis	0.000492	0.00103	CcSEcCtD
Solifenacin—Feeling abnormal—Prednisone—rheumatoid arthritis	0.000488	0.00102	CcSEcCtD
Solifenacin—Asthenia—Betamethasone—rheumatoid arthritis	0.000488	0.00102	CcSEcCtD
Solifenacin—Asthenia—Dexamethasone—rheumatoid arthritis	0.000488	0.00102	CcSEcCtD
Solifenacin—Nervous system disorder—Methotrexate—rheumatoid arthritis	0.000485	0.00101	CcSEcCtD
Solifenacin—Gastrointestinal pain—Prednisone—rheumatoid arthritis	0.000484	0.00101	CcSEcCtD
Solifenacin—Nausea—Prednisolone—rheumatoid arthritis	0.000484	0.00101	CcSEcCtD
Solifenacin—Pruritus—Dexamethasone—rheumatoid arthritis	0.000481	0.001	CcSEcCtD
Solifenacin—Pruritus—Betamethasone—rheumatoid arthritis	0.000481	0.001	CcSEcCtD
Solifenacin—Skin disorder—Methotrexate—rheumatoid arthritis	0.000481	0.001	CcSEcCtD
Solifenacin—Vomiting—Triamcinolone—rheumatoid arthritis	0.000476	0.000994	CcSEcCtD
Solifenacin—Vomiting—Methylprednisolone—rheumatoid arthritis	0.000475	0.000992	CcSEcCtD
Solifenacin—Nausea—Hydrocortisone—rheumatoid arthritis	0.000473	0.000986	CcSEcCtD
Solifenacin—Rash—Triamcinolone—rheumatoid arthritis	0.000472	0.000986	CcSEcCtD
Solifenacin—Dermatitis—Triamcinolone—rheumatoid arthritis	0.000472	0.000985	CcSEcCtD
Solifenacin—Rash—Methylprednisolone—rheumatoid arthritis	0.000471	0.000984	CcSEcCtD
Solifenacin—Dermatitis—Methylprednisolone—rheumatoid arthritis	0.000471	0.000983	CcSEcCtD
Solifenacin—Urticaria—Prednisone—rheumatoid arthritis	0.00047	0.000982	CcSEcCtD
Solifenacin—Headache—Triamcinolone—rheumatoid arthritis	0.000469	0.00098	CcSEcCtD
Solifenacin—Headache—Methylprednisolone—rheumatoid arthritis	0.000468	0.000977	CcSEcCtD
Solifenacin—Abdominal pain—Prednisone—rheumatoid arthritis	0.000468	0.000977	CcSEcCtD
Solifenacin—Dizziness—Dexamethasone—rheumatoid arthritis	0.00045	0.000938	CcSEcCtD
Solifenacin—Dizziness—Betamethasone—rheumatoid arthritis	0.00045	0.000938	CcSEcCtD
Solifenacin—Nausea—Triamcinolone—rheumatoid arthritis	0.000445	0.000929	CcSEcCtD
Solifenacin—Nausea—Methylprednisolone—rheumatoid arthritis	0.000444	0.000927	CcSEcCtD
Solifenacin—Somnolence—Methotrexate—rheumatoid arthritis	0.00044	0.000918	CcSEcCtD
Solifenacin—Hypersensitivity—Prednisone—rheumatoid arthritis	0.000436	0.00091	CcSEcCtD
Solifenacin—Dyspepsia—Methotrexate—rheumatoid arthritis	0.000436	0.000909	CcSEcCtD
Solifenacin—Vomiting—Betamethasone—rheumatoid arthritis	0.000432	0.000902	CcSEcCtD
Solifenacin—Vomiting—Dexamethasone—rheumatoid arthritis	0.000432	0.000902	CcSEcCtD
Solifenacin—Decreased appetite—Methotrexate—rheumatoid arthritis	0.00043	0.000898	CcSEcCtD
Solifenacin—Rash—Dexamethasone—rheumatoid arthritis	0.000429	0.000895	CcSEcCtD
Solifenacin—Rash—Betamethasone—rheumatoid arthritis	0.000429	0.000895	CcSEcCtD
Solifenacin—Dermatitis—Betamethasone—rheumatoid arthritis	0.000428	0.000894	CcSEcCtD
Solifenacin—Dermatitis—Dexamethasone—rheumatoid arthritis	0.000428	0.000894	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	0.000427	0.000892	CcSEcCtD
Solifenacin—Fatigue—Methotrexate—rheumatoid arthritis	0.000427	0.00089	CcSEcCtD
Solifenacin—Headache—Betamethasone—rheumatoid arthritis	0.000426	0.000889	CcSEcCtD
Solifenacin—Headache—Dexamethasone—rheumatoid arthritis	0.000426	0.000889	CcSEcCtD
Solifenacin—Asthenia—Prednisone—rheumatoid arthritis	0.000425	0.000887	CcSEcCtD
Solifenacin—Pruritus—Prednisone—rheumatoid arthritis	0.000419	0.000874	CcSEcCtD
Solifenacin—Feeling abnormal—Methotrexate—rheumatoid arthritis	0.000408	0.000851	CcSEcCtD
Solifenacin—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	0.000405	0.000844	CcSEcCtD
Solifenacin—Nausea—Betamethasone—rheumatoid arthritis	0.000404	0.000843	CcSEcCtD
Solifenacin—Nausea—Dexamethasone—rheumatoid arthritis	0.000404	0.000843	CcSEcCtD
Solifenacin—Urticaria—Methotrexate—rheumatoid arthritis	0.000393	0.00082	CcSEcCtD
Solifenacin—Dizziness—Prednisone—rheumatoid arthritis	0.000392	0.000817	CcSEcCtD
Solifenacin—Abdominal pain—Methotrexate—rheumatoid arthritis	0.000391	0.000816	CcSEcCtD
Solifenacin—Vomiting—Prednisone—rheumatoid arthritis	0.000376	0.000786	CcSEcCtD
Solifenacin—Rash—Prednisone—rheumatoid arthritis	0.000373	0.000779	CcSEcCtD
Solifenacin—Dermatitis—Prednisone—rheumatoid arthritis	0.000373	0.000778	CcSEcCtD
Solifenacin—Headache—Prednisone—rheumatoid arthritis	0.000371	0.000774	CcSEcCtD
Solifenacin—Hypersensitivity—Methotrexate—rheumatoid arthritis	0.000365	0.000761	CcSEcCtD
Solifenacin—Asthenia—Methotrexate—rheumatoid arthritis	0.000355	0.000741	CcSEcCtD
Solifenacin—Nausea—Prednisone—rheumatoid arthritis	0.000352	0.000734	CcSEcCtD
Solifenacin—Pruritus—Methotrexate—rheumatoid arthritis	0.00035	0.000731	CcSEcCtD
Solifenacin—Dizziness—Methotrexate—rheumatoid arthritis	0.000327	0.000683	CcSEcCtD
Solifenacin—Vomiting—Methotrexate—rheumatoid arthritis	0.000315	0.000657	CcSEcCtD
Solifenacin—Rash—Methotrexate—rheumatoid arthritis	0.000312	0.000651	CcSEcCtD
Solifenacin—Dermatitis—Methotrexate—rheumatoid arthritis	0.000312	0.00065	CcSEcCtD
Solifenacin—Headache—Methotrexate—rheumatoid arthritis	0.00031	0.000647	CcSEcCtD
Solifenacin—Nausea—Methotrexate—rheumatoid arthritis	0.000294	0.000613	CcSEcCtD
Solifenacin—CHRM4—Signaling Pathways—MMP3—rheumatoid arthritis	5.07e-05	0.000354	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—TYK2—rheumatoid arthritis	5.06e-05	0.000354	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CXCL2—rheumatoid arthritis	4.98e-05	0.000348	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CCL3—rheumatoid arthritis	4.98e-05	0.000348	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CXCL2—rheumatoid arthritis	4.97e-05	0.000347	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CCL3—rheumatoid arthritis	4.97e-05	0.000347	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CCL3—rheumatoid arthritis	4.92e-05	0.000344	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CXCL2—rheumatoid arthritis	4.92e-05	0.000344	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—CCR5—rheumatoid arthritis	4.92e-05	0.000343	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—CCR5—rheumatoid arthritis	4.9e-05	0.000342	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—PTK2—rheumatoid arthritis	4.88e-05	0.000341	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—SAA1—rheumatoid arthritis	4.87e-05	0.00034	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PLD4—rheumatoid arthritis	4.87e-05	0.00034	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—SAA1—rheumatoid arthritis	4.86e-05	0.000339	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—CXCL8—rheumatoid arthritis	4.85e-05	0.000339	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—CCR5—rheumatoid arthritis	4.85e-05	0.000339	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—MMP3—rheumatoid arthritis	4.85e-05	0.000339	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—TYK2—rheumatoid arthritis	4.85e-05	0.000339	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—IL2RA—rheumatoid arthritis	4.85e-05	0.000338	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—IL2RA—rheumatoid arthritis	4.83e-05	0.000337	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—SAA1—rheumatoid arthritis	4.81e-05	0.000336	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—C3—rheumatoid arthritis	4.8e-05	0.000336	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—C3—rheumatoid arthritis	4.79e-05	0.000334	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—IL2RA—rheumatoid arthritis	4.78e-05	0.000334	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CCL5—rheumatoid arthritis	4.78e-05	0.000334	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NCF1—rheumatoid arthritis	4.77e-05	0.000333	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NCF1—rheumatoid arthritis	4.76e-05	0.000332	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—C3—rheumatoid arthritis	4.74e-05	0.000331	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NCF1—rheumatoid arthritis	4.71e-05	0.000329	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CSF2—rheumatoid arthritis	4.71e-05	0.000329	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ACAN—rheumatoid arthritis	4.7e-05	0.000328	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—PTK2—rheumatoid arthritis	4.67e-05	0.000326	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—CXCL8—rheumatoid arthritis	4.65e-05	0.000325	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—IL2—rheumatoid arthritis	4.64e-05	0.000324	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CD28—rheumatoid arthritis	4.59e-05	0.000321	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CCL5—rheumatoid arthritis	4.58e-05	0.00032	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CD28—rheumatoid arthritis	4.58e-05	0.00032	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CD28—rheumatoid arthritis	4.53e-05	0.000316	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CSF2—rheumatoid arthritis	4.51e-05	0.000315	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—IL2—rheumatoid arthritis	4.44e-05	0.00031	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—SPP1—rheumatoid arthritis	4.43e-05	0.000309	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—SLC25A12—rheumatoid arthritis	4.42e-05	0.000309	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—CXCL8—rheumatoid arthritis	4.41e-05	0.000308	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—UBE2D1—rheumatoid arthritis	4.32e-05	0.000302	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CCR5—rheumatoid arthritis	4.31e-05	0.000301	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—UBE2D1—rheumatoid arthritis	4.31e-05	0.000301	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GC—rheumatoid arthritis	4.3e-05	0.0003	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PTGES—rheumatoid arthritis	4.3e-05	0.0003	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—UBE2D1—rheumatoid arthritis	4.27e-05	0.000298	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IL2RA—rheumatoid arthritis	4.25e-05	0.000296	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—SPP1—rheumatoid arthritis	4.24e-05	0.000296	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—BDKRB2—rheumatoid arthritis	4.24e-05	0.000296	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CXCL12—rheumatoid arthritis	4.24e-05	0.000296	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—POMC—rheumatoid arthritis	4.23e-05	0.000296	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—BDKRB2—rheumatoid arthritis	4.22e-05	0.000295	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CXCL12—rheumatoid arthritis	4.22e-05	0.000295	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—CXCL8—rheumatoid arthritis	4.22e-05	0.000295	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—POMC—rheumatoid arthritis	4.22e-05	0.000295	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—IL2—rheumatoid arthritis	4.21e-05	0.000294	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—C3—rheumatoid arthritis	4.21e-05	0.000294	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—IL6ST—rheumatoid arthritis	4.2e-05	0.000293	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—ADRBK1—rheumatoid arthritis	4.19e-05	0.000293	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—IL6ST—rheumatoid arthritis	4.19e-05	0.000292	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—BDKRB2—rheumatoid arthritis	4.18e-05	0.000292	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CXCL12—rheumatoid arthritis	4.18e-05	0.000292	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—POMC—rheumatoid arthritis	4.18e-05	0.000292	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—ADRBK1—rheumatoid arthritis	4.18e-05	0.000292	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—IL6ST—rheumatoid arthritis	4.15e-05	0.00029	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—ADRBK1—rheumatoid arthritis	4.14e-05	0.000289	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CCR5—rheumatoid arthritis	4.13e-05	0.000288	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IL2RA—rheumatoid arthritis	4.07e-05	0.000284	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—CAT—rheumatoid arthritis	4.05e-05	0.000283	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—IL2—rheumatoid arthritis	4.03e-05	0.000282	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—C3—rheumatoid arthritis	4.03e-05	0.000282	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PLB1—rheumatoid arthritis	4e-05	0.000279	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—RASGRP1—rheumatoid arthritis	3.95e-05	0.000276	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—RASGRP1—rheumatoid arthritis	3.94e-05	0.000275	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—SYK—rheumatoid arthritis	3.94e-05	0.000275	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—SYK—rheumatoid arthritis	3.93e-05	0.000274	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—LEP—rheumatoid arthritis	3.92e-05	0.000274	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—RASGRP1—rheumatoid arthritis	3.9e-05	0.000272	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—SYK—rheumatoid arthritis	3.89e-05	0.000272	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PRKCQ—rheumatoid arthritis	3.87e-05	0.00027	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PRKCQ—rheumatoid arthritis	3.85e-05	0.000269	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—POMC—rheumatoid arthritis	3.84e-05	0.000268	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—POMC—rheumatoid arthritis	3.83e-05	0.000267	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PRKCQ—rheumatoid arthritis	3.82e-05	0.000267	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—STAT1—rheumatoid arthritis	3.8e-05	0.000265	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—POMC—rheumatoid arthritis	3.79e-05	0.000265	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—STAT1—rheumatoid arthritis	3.79e-05	0.000264	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—CCL2—rheumatoid arthritis	3.76e-05	0.000263	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—LEP—rheumatoid arthritis	3.75e-05	0.000262	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—STAT1—rheumatoid arthritis	3.75e-05	0.000262	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—IL6R—rheumatoid arthritis	3.75e-05	0.000262	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—CCL2—rheumatoid arthritis	3.75e-05	0.000262	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CXCL10—rheumatoid arthritis	3.75e-05	0.000262	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—IL6R—rheumatoid arthritis	3.74e-05	0.000261	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CXCL10—rheumatoid arthritis	3.73e-05	0.000261	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—CCL2—rheumatoid arthritis	3.71e-05	0.000259	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—IL6R—rheumatoid arthritis	3.7e-05	0.000258	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CXCL10—rheumatoid arthritis	3.7e-05	0.000258	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—FN1—rheumatoid arthritis	3.7e-05	0.000258	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IL6ST—rheumatoid arthritis	3.68e-05	0.000257	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CD80—rheumatoid arthritis	3.54e-05	0.000247	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—FN1—rheumatoid arthritis	3.54e-05	0.000247	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IL6ST—rheumatoid arthritis	3.53e-05	0.000246	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—MED1—rheumatoid arthritis	3.51e-05	0.000245	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MMP3—rheumatoid arthritis	3.42e-05	0.000239	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—TYK2—rheumatoid arthritis	3.41e-05	0.000238	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MMP3—rheumatoid arthritis	3.41e-05	0.000238	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—TYK2—rheumatoid arthritis	3.4e-05	0.000238	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CD80—rheumatoid arthritis	3.39e-05	0.000237	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—MTHFR—rheumatoid arthritis	3.38e-05	0.000236	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MMP3—rheumatoid arthritis	3.37e-05	0.000235	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—TYK2—rheumatoid arthritis	3.37e-05	0.000235	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—POMC—rheumatoid arthritis	3.37e-05	0.000235	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CCL2—rheumatoid arthritis	3.29e-05	0.00023	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PTK2—rheumatoid arthritis	3.29e-05	0.00023	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IL6R—rheumatoid arthritis	3.28e-05	0.000229	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PTK2—rheumatoid arthritis	3.28e-05	0.000229	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—CXCL8—rheumatoid arthritis	3.27e-05	0.000229	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—CXCL8—rheumatoid arthritis	3.26e-05	0.000228	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	3.26e-05	0.000228	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	3.26e-05	0.000228	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PTK2—rheumatoid arthritis	3.25e-05	0.000227	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—CXCL8—rheumatoid arthritis	3.23e-05	0.000226	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—POMC—rheumatoid arthritis	3.22e-05	0.000225	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CCL5—rheumatoid arthritis	3.22e-05	0.000225	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CCL5—rheumatoid arthritis	3.21e-05	0.000224	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CCL5—rheumatoid arthritis	3.18e-05	0.000222	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CSF2—rheumatoid arthritis	3.18e-05	0.000222	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CSF2—rheumatoid arthritis	3.17e-05	0.000221	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CCL2—rheumatoid arthritis	3.15e-05	0.00022	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IL6R—rheumatoid arthritis	3.15e-05	0.00022	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CSF2—rheumatoid arthritis	3.13e-05	0.000219	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—IL2—rheumatoid arthritis	3.13e-05	0.000218	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—IL2—rheumatoid arthritis	3.12e-05	0.000218	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—IL2—rheumatoid arthritis	3.09e-05	0.000216	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—TYK2—rheumatoid arthritis	2.99e-05	0.000209	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—SPP1—rheumatoid arthritis	2.99e-05	0.000209	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—SPP1—rheumatoid arthritis	2.98e-05	0.000208	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—CXCL8—rheumatoid arthritis	2.97e-05	0.000208	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—CXCL8—rheumatoid arthritis	2.96e-05	0.000207	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—SPP1—rheumatoid arthritis	2.95e-05	0.000206	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—NOS3—rheumatoid arthritis	2.94e-05	0.000205	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—BGN—rheumatoid arthritis	2.94e-05	0.000205	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—CXCL8—rheumatoid arthritis	2.93e-05	0.000205	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CCR5—rheumatoid arthritis	2.9e-05	0.000203	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CCR5—rheumatoid arthritis	2.9e-05	0.000202	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CCR5—rheumatoid arthritis	2.87e-05	0.0002	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—TYK2—rheumatoid arthritis	2.86e-05	0.0002	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IL2RA—rheumatoid arthritis	2.86e-05	0.0002	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IL2RA—rheumatoid arthritis	2.85e-05	0.000199	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—IL2—rheumatoid arthritis	2.84e-05	0.000198	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—C3—rheumatoid arthritis	2.84e-05	0.000198	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—IL2—rheumatoid arthritis	2.83e-05	0.000198	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—C3—rheumatoid arthritis	2.83e-05	0.000198	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IL2RA—rheumatoid arthritis	2.83e-05	0.000197	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—NOS3—rheumatoid arthritis	2.81e-05	0.000196	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—IL2—rheumatoid arthritis	2.8e-05	0.000196	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—C3—rheumatoid arthritis	2.8e-05	0.000196	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—POMC—rheumatoid arthritis	2.71e-05	0.000189	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	2.7e-05	0.000189	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—LEP—rheumatoid arthritis	2.64e-05	0.000185	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—LEP—rheumatoid arthritis	2.63e-05	0.000184	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—LEP—rheumatoid arthritis	2.61e-05	0.000182	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CXCL8—rheumatoid arthritis	2.6e-05	0.000182	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CXCL8—rheumatoid arthritis	2.49e-05	0.000174	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—FN1—rheumatoid arthritis	2.49e-05	0.000174	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IL2—rheumatoid arthritis	2.49e-05	0.000174	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—FN1—rheumatoid arthritis	2.48e-05	0.000173	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IL6ST—rheumatoid arthritis	2.48e-05	0.000173	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—IL6—rheumatoid arthritis	2.48e-05	0.000173	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IL6ST—rheumatoid arthritis	2.47e-05	0.000173	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—ALB—rheumatoid arthritis	2.47e-05	0.000172	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—FN1—rheumatoid arthritis	2.46e-05	0.000172	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IL6ST—rheumatoid arthritis	2.45e-05	0.000171	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CD80—rheumatoid arthritis	2.39e-05	0.000167	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IL2—rheumatoid arthritis	2.38e-05	0.000166	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CD80—rheumatoid arthritis	2.38e-05	0.000166	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—IL6—rheumatoid arthritis	2.37e-05	0.000166	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—NOS3—rheumatoid arthritis	2.36e-05	0.000165	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CD80—rheumatoid arthritis	2.36e-05	0.000165	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—MMP9—rheumatoid arthritis	2.36e-05	0.000164	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—NFKB1—rheumatoid arthritis	2.33e-05	0.000163	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—MAPK8—rheumatoid arthritis	2.29e-05	0.00016	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—POMC—rheumatoid arthritis	2.27e-05	0.000159	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—POMC—rheumatoid arthritis	2.26e-05	0.000158	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—MMP9—rheumatoid arthritis	2.26e-05	0.000158	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—POMC—rheumatoid arthritis	2.24e-05	0.000156	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—NFKB1—rheumatoid arthritis	2.23e-05	0.000156	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CCL2—rheumatoid arthritis	2.22e-05	0.000155	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IL6R—rheumatoid arthritis	2.21e-05	0.000155	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CCL2—rheumatoid arthritis	2.21e-05	0.000155	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IL6R—rheumatoid arthritis	2.21e-05	0.000154	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	2.2e-05	0.000154	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—MAPK8—rheumatoid arthritis	2.19e-05	0.000153	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CCL2—rheumatoid arthritis	2.19e-05	0.000153	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IL6R—rheumatoid arthritis	2.19e-05	0.000153	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PTGS2—rheumatoid arthritis	2.16e-05	0.000151	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—VEGFA—rheumatoid arthritis	2.12e-05	0.000148	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—VEGFA—rheumatoid arthritis	2.03e-05	0.000141	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—TYK2—rheumatoid arthritis	2.02e-05	0.000141	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—TYK2—rheumatoid arthritis	2.01e-05	0.00014	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—TYK2—rheumatoid arthritis	1.99e-05	0.000139	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NOS3—rheumatoid arthritis	1.98e-05	0.000138	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NOS3—rheumatoid arthritis	1.97e-05	0.000138	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NOS3—rheumatoid arthritis	1.95e-05	0.000136	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—TGFB1—rheumatoid arthritis	1.94e-05	0.000136	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—TGFB1—rheumatoid arthritis	1.86e-05	0.00013	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CXCL8—rheumatoid arthritis	1.76e-05	0.000123	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CXCL8—rheumatoid arthritis	1.75e-05	0.000122	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CXCL8—rheumatoid arthritis	1.73e-05	0.000121	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IL2—rheumatoid arthritis	1.68e-05	0.000117	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IL2—rheumatoid arthritis	1.67e-05	0.000117	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—IL6—rheumatoid arthritis	1.67e-05	0.000117	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—IL6—rheumatoid arthritis	1.66e-05	0.000116	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IL2—rheumatoid arthritis	1.66e-05	0.000116	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—IL6—rheumatoid arthritis	1.65e-05	0.000115	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—TP53—rheumatoid arthritis	1.6e-05	0.000112	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MMP9—rheumatoid arthritis	1.59e-05	0.000111	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CAT—rheumatoid arthritis	1.58e-05	0.000111	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MMP9—rheumatoid arthritis	1.58e-05	0.000111	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NFKB1—rheumatoid arthritis	1.57e-05	0.00011	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MMP9—rheumatoid arthritis	1.57e-05	0.000109	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NFKB1—rheumatoid arthritis	1.57e-05	0.000109	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NFKB1—rheumatoid arthritis	1.55e-05	0.000108	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MAPK8—rheumatoid arthritis	1.54e-05	0.000108	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MAPK8—rheumatoid arthritis	1.54e-05	0.000108	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—TP53—rheumatoid arthritis	1.53e-05	0.000107	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MAPK8—rheumatoid arthritis	1.52e-05	0.000106	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IL6—rheumatoid arthritis	1.46e-05	0.000102	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—VEGFA—rheumatoid arthritis	1.43e-05	9.96e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—VEGFA—rheumatoid arthritis	1.42e-05	9.93e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—VEGFA—rheumatoid arthritis	1.41e-05	9.83e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IL6—rheumatoid arthritis	1.4e-05	9.78e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	1.32e-05	9.24e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—TGFB1—rheumatoid arthritis	1.31e-05	9.14e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—TGFB1—rheumatoid arthritis	1.3e-05	9.11e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—TGFB1—rheumatoid arthritis	1.29e-05	9.02e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—TP53—rheumatoid arthritis	1.08e-05	7.53e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—TP53—rheumatoid arthritis	1.07e-05	7.5e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—TP53—rheumatoid arthritis	1.06e-05	7.43e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—POMC—rheumatoid arthritis	1.06e-05	7.39e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IL6—rheumatoid arthritis	9.86e-06	6.89e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IL6—rheumatoid arthritis	9.83e-06	6.87e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IL6—rheumatoid arthritis	9.74e-06	6.8e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ALB—rheumatoid arthritis	9.65e-06	6.74e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	9.23e-06	6.44e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	8.44e-06	5.89e-05	CbGpPWpGaD
